NEW YORK, September 23, 2015 /PRNewswire/ --
ACI Association has initiated research coverage on the following equities: Geron Corporation (NASDAQ: GERN), ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA), Endo International plc (NASDAQ: ENDP), Express Scripts Holding Company (NASDAQ: ESRX), Depomed, Inc. (NASDAQ: DEPO). On Tuesday, September 22, 2015, NASDAQ ended at 4,756.72 down 1.50%, DOW declined 1.09%, to finish the day at 16,330.47, and the S&P closed at 1,942.74, down 1.23%. Register for your complimentary reports at the links given below.
--
Geron Corp
--
Geron Corp's stock edged lower by 3.86% to close Tuesday's session at USD 3.24. The company's shares oscillated between USD 3.18 and USD 3.40. The stock recorded a trading volume of 4.02 million shares, which was above its 50-day daily average volume of 2.68 million shares. Over the last three days, Geron Corp's shares have declined by 13.14% and in the past one week it has moved down 8.73%. Furthermore, over the last three months, the stock has lost 25.00% and in the past six months, the shares have shed 14.29%. On a compounded total return basis, the stock has returned 5.19% in the past one month, but has shown a negative return of 22.30% in the past three months. The stock is trading at a price to book ratio of 4.33, while the historical PB ratio is near to 3.91. Sign up and read the free notes on GERN at: http://www.aciassociation.com/GERN.pdf
--
ARIAD Pharmaceuticals Inc
--
The stock of ARIAD Pharmaceuticals Inc lost 3.68% to close Tuesday's session at USD 7.32. The shares of the company moved in the range of USD 7.19 and USD 7.61. A trading volume of 3.76 million shares was recorded, which was lower than its 150-day daily average volume of 4.78 million shares. Over the last five days, ARIAD Pharmaceuticals Inc's shares have declined by 8.84% and in the past one month, it has gained a momentum of 9.91%. Additionally, over the last three months, the stock has declined 17.66% and in the past six months, the shares have registered a loss of 12.65%. The stock has returned 10.41% in the past one month, but has shown a negative return of 17.47% in the last three months, on a compounded total return basis. Register for free on ACI Association and access the latest research on ARIA at: http://www.aciassociation.com/ARIA.pdf
--
Endo International PLC
--
Endo International PLC's stock decreased by 3.26% to close Tuesday's session at USD 75.78. The company's shares fluctuated in the range of USD 73.80 and USD 77.65. A total of 3.46 million shares exchanged hands, which surpassed its 50-day daily average volume of 2.05 million shares. Over the last three days Endo International PLC's shares have declined by 6.43% and in the past one week it has moved down 0.25%. The stock has shown a negative return of 9.96% in the past three months on a compounded total return basis. The stock is trading at a price to book ratio of 2.56, while the historical PB ratio is near to 4.67. Additionally, the stock is trading at a price to cash flow ratio of 12999.40 and price to sales ratio of 5.24. The complete research on ENDP is available for free at: http://www.aciassociation.com/ENDP.pdf
--
Express Scripts Holding Co
--
Express Scripts Holding Co's stock slipped by 0.96% to close Tuesday's session at USD 82.81. The stock recorded a trading volume of 3.27 million shares, which was below its 50-day daily average volume of 4.54 million shares. Over the last five days, Express Scripts Holding Co's shares have declined by 2.61% and in the past one month, it has lost 6.04%. The stock has shown a negative return of 3.01% in the last six months, but a positive return of 15.09% in the past one year, on a compounded total return basis. The company is trading at a price to earnings ratio of 27.15, compared to a historical PE ratio of 32.01. Further, the stock is at a price to book ratio of 3.54, while the historical PB ratio is near to 3.07. Additionally, the stock is trading at a price to cash flow ratio of 13.35. Free in-depth research on ESRX is available at: http://www.aciassociation.com/ESRX.pdf
--
Depomed Inc
--
Depomed Inc's stock declined 12.68% to close Tuesday's session at USD 24.18. The share price vacillated between USD 24.07 and USD 27.26. The stock recorded a trading volume of 2.48 million shares, which was above its 50-day daily average volume of 1.56 million shares. Over the last three days Depomed Inc's shares have declined by 15.87% and in the past one week it has moved down 13.18%. On a compounded total return basis, the company has returned 3.07% in the last three months, and 0.25% in the last half a year. The stock is trading at a price to earnings ratio of 31.00, compared to a historical PE ratio of 7.85. Further, the stock is at a price to book ratio of 4.21, while the historical PB ratio is near to 2.62. The complimentary notes on DEPO can be downloaded in PDF format at: http://www.aciassociation.com/DEPO.pdf
--
About ACI Association:
Active Charter Investors Association ("ACI Association") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. ACI Association has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
ACI Association has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.
NO WARRANTY
ACI Association, the Author, the Reviewer and the Sponsor (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither ACI Association nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.aciassociation.com/.
RESTRICTIONS
ACI Association is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE www.aciassociation.com
